ANNA WHITTINGTON: Open Payments
NPI 1568700490 · MELBOURNE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$831 in 34 payments from 12 companies in 2025. Trend: 2023 $1,409 · 2024 $1,328 · 2025 $831
Food & beverage: $831
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $207 |
| GENZYME CORPORATION | 3 | $140 |
| E.R. Squibb & Sons, L.L.C. | 1 | $121 |
| Novartis Pharmaceuticals Corporation | 5 | $94 |
| LEO Pharma Inc. | 2 | $56 |
| Almirall LLC | 2 | $51 |
| Incyte Corporation | 2 | $47 |
| Botanix SB Inc | 2 | $36 |
| Verrica Pharmaceuticals Inc. | 1 | $23 |
| Organon LLC | 4 | $20 |
Products named: SKYRIZI, DUPIXENT, Sotyktu, RINVOQ, Rhapsido, ADBRY, Klisyri, OPZELURA.
Industry payments across FL — which companies pay providers there.
